Depression and Anxiety Trial, Recruiting NCT03896529 Sponsor: Georgia Institute of Technology Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT03896529
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 65 and 80
  • People who are U.S. citizens or permanent residents
  • People who speak fluent English
  • People who are willing to travel to Georgia Tech to take part in group testing sessions

Who may not be able to join:

  • People who have metal or electrical implants, a heart rhythm condition, or who take medications that affect the heart or blood vessels (such as beta-blockers), as these may be safety concerns for MRI and electrical stimulation used in the study (confirm with trial site)
  • People who have epilepsy
  • People who have dementia
  • People who have Parkinson's disease
  • People with a history of stroke or seizures
  • People with psychiatric disorders
  • People with untreated depression or other untreated emotional conditions
  • People with Attention Deficit Disorder
  • People with Multiple Sclerosis
  • People with uncontrolled high or low blood pressure
  • People with untreated diabetes
  • People with Sickle Cell Anemia
  • People who regularly use illegal or psychoactive drugs, including alcohol misuse
  • People whose results on certain memory and thinking screening tests fall below the thresholds set by the study, which are used to identify signs of mild cognitive impairment or early dementia (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thackery I Brown, Ph.D., Georgia Institute of Technology

Phone: 404-894-1123

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Georgia Institute of Technology
Registry
ClinicalTrials.gov
Start date
24 September 2019
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Behavioral probability of taking a shortcut between control and treatment groups; fMRI activation level between control and treatment groups; Neural memory representation reactivation between control and treatment groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov